Skip to main content

Table 5 Summary of validation parameters for proposed investigation

From: Reverse phase-liquid chromatography assisted protocol for simultaneous determination of lamivudine and tenofovir disoproxil fumarate in combined medication used to control HIV infection: an investigative approach

Parameters

RP-HPLC

LVD

TDF

Linearity

 Range (μg/mL)

10–50

 Determination coefficient (r2)

0.995

0.996

Accuracy

 Mean percent recovery (%)

99.19–100.05

99.21–100.01

 RSD %

00.20–0.72

0.10–0.83

Precision

 Intra-day precision (RSD %)

0.26–1.64

0.10–1.15

 Inter-day precision (RSD %)

0.35–0.44

0.40–0.68

 Repeatability (RSD %)

0.57

0.71

Sensitivity

 LOD (μg)

0.10

0.25

 LOQ (μg

0.32

0.45

Robustness

Robust

Ruggedness

 Analysts-I (mean ± SD)

99.24 ± 0.14

99.45 ± 0.19

 Analysts-II (mean ± SD)

99.95 ± 0.25

99.69 ± 0.27

Specificity

Specific

% Assay of drugs

99.78 ± 0.24

99.50 ± 0.17

  1. *SD Standard deviation, %RSD Percent relative standard deviation